Blockade of the co-inhibitory molecule PD-1 unleashes ILC2-dependent antitumor immunity in melanoma

- Jacquelot, Nicolas, Seillet, Cyril, Souza-Fonseca-Guimaraes, Fernando, de Graaf, Carolyn A., Thia, Kevin, Macdonald, Sean, Camilleri, Mary, Luong, Kylie, Zhang, Shengbo, Chopin, Michael, Molden-Hauer, T., Nutt, S. L., Wang, Minyu, Umansky, V., Ciric, B., Groom, J.R., Foster, Paul S., Hansbro, Philip M., McKenzie, A. N. J., Gray, D .H .D., Behren, A., Cebon, J., Vivier, E., Pizzolla, Angela, Wicks, I. P., Trapani, J. A., Munitz, A., Davis, M. J., Shi, W., Neeson, P. J., Belz, G. T., Liao, Yang, Hediyeh-zadeh, Soroor, Grisaru-Tal, Sharon, Louis, Cynthia, Huang, Qiutong, Schreuder, Jaring

Endocytosis inhibition in humans to improve responses to ADCC-mediating antibodies

- Chew, Hui Yi, De Lima, Priscilia O., Gonzalez Cruz, Jazmina L., Banushi, Blerida, Echejoh, Godwins, Hu, Lingbo, Joseph, Shannon R., Lum, Benedict, Rae, James, O'Donnell, Jake S., de Long, Lilia Merida, Okano, Satomi, King, Brigid, Barry, Rachael, Moi, Davide, Mazzieri, Roberta, Thomas, Ranjeny, Souza-Fonseca-Guimaraes, Fernando, Foote, Matthew, McCluskey, Adam, Martin, Jennifer H., Robinson, Philip J., Frazer, IH, Saunders, NA, Parton, RG, Dolcetti, R, Cuff, K, Panizza, B, Walpole, E, Wells, JW, Simpson, F